AYURVEDIC TREATMENT OF OBESITY - A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL

被引:19
|
作者
PARANJPE, P
PATKI, P
PATWARDHAN, B
机构
[1] UNIV POONA,INTERDISCIPLINARY SCH AYURVED MED,POONA 411007,MAHARASHTRA,INDIA
[2] NANAL HOSP,OBES CLIN,POONA 411004,INDIA
[3] BYRAMJEE JEEJEEBHOY MED COLL,POONA 411001,INDIA
关键词
D O I
10.1016/0378-8741(90)90092-8
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Seventy obese subjects were randomised into four groups. Ayurvedic drug treatments were given for three months while one group received a placebo. Physical, clinical and pathological investigations were carried out at regular intervals. A significant weight loss was observed in drug therapy groups when compared with the placebo. Body measurements such as skin fold thickness and hip and waist circumferences were significantly decreased. Decreases in serum cholesterol and triglycloride levels were observed. No side effects of any kind were observed during the treatment period. © 1990.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [1] LEVAMISOLE IN CROHNS-DISEASE - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL
    SACHAR, DB
    RUBIN, KP
    GUMASTE, V
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1987, 82 (06): : 536 - 539
  • [2] AZODISALICYLATE SODIUM IN THE TREATMENT OF ULCERATIVE-COLITIS - A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL
    ROBINSON, MG
    DORROUGH, C
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1987, 82 (09): : 953 - 953
  • [3] A PLACEBO-CONTROLLED, DOUBLE-BLIND, CLINICAL-TRIAL OF PAROXETINE IN DEPRESSED OUTPATIENTS
    RICKELS, K
    AMSTERDAM, J
    CLARY, C
    FOX, I
    SCHWEIZER, E
    WEISE, C
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1989, 80 : 117 - 123
  • [4] OUTCOME MEASURES IN RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND MULTIPLE-SCLEROSIS CLINICAL-TRIAL
    NOSEWORTHY, JH
    OBRIEN, PC
    NAESSENS, JM
    [J]. NEUROLOGY, 1994, 44 (04) : A392 - A392
  • [5] TREATMENT OF PREMENSTRUAL-SYNDROME WITH ALPRAZOLAM - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CROSSOVER CLINICAL-TRIAL
    SMITH, S
    RINEHART, JS
    RUDDOCK, VE
    SCHIFF, I
    [J]. OBSTETRICS AND GYNECOLOGY, 1987, 70 (01): : 37 - 43
  • [6] OLSALAZINE IN THE TREATMENT OF MILD TO MODERATE ULCERATIVE-COLITIS - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, CLINICAL-TRIAL
    FEURLE, GE
    THEUER, D
    VELASCO, S
    BARRY, BA
    WORDEHOFF, D
    SOMMER, A
    JANTSCHEGK, Y
    KRUIS, W
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 : 38 - 39
  • [7] A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis
    Nassiri-Kashani, M
    Firooz, A
    Khamesipour, A
    Moitahed, F
    Nilforoushzadeh, M
    Hejazi, H
    Bouzari, N
    Dowlati, Y
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 (01) : 80 - 83
  • [8] Atorvastatin Treatment For Pulmonary Sarcoidosis, A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Fontana, J. R.
    Moss, J.
    Stylianou, M.
    Levine, S. J.
    Barochia, A. V.
    Weir, N.
    Parrish, S.
    Lazarus, A.
    Nations, J. A.
    McKay, S.
    Browning, R.
    MacDonald, S.
    May, R.
    Haughey, M.
    McGraw, P.
    Barton, M.
    Guerriero, M.
    Jolley, C.
    Folio, L. R.
    Siegelman, J.
    Kaneshiro, R.
    Bea, V. Jolley
    Bahrami, G.
    Manganiello, V. C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [9] Trimethoprim as Adjuvant Treatment in Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Shibre, Teshome
    Alem, Atalay
    Abdulahi, Abdulreshid
    Araya, Mesfin
    Beyero, Teferra
    Medhin, Girmay
    Deyassa, Negusse
    Negash, Alemayehu
    Nigatu, Alemayehu
    Kebede, Derege
    Fekadu, Abebaw
    [J]. SCHIZOPHRENIA BULLETIN, 2010, 36 (04) : 846 - 851
  • [10] Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial
    Rossignol, J. -F.
    El-Gohary, Y. M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (10) : 1423 - 1430